Johnson Investment Counsel’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $616K | Sell |
11,753
-982
| -8% | -$51.9K | ﹤0.01% | 559 |
|
|
2026
Q1 | $703K | Sell |
12,735
-1,709
| -12% | -$92.6K | 0.01% | 501 |
|
|
2025
Q4 | $708K | Sell |
14,444
-546
| -4% | -$25.5K | 0.01% | 472 |
|
|
2025
Q3 | $647K | Sell |
14,990
-728
| -5% | -$28.4K | 0.01% | 522 |
|
|
2025
Q2 | $604K | Buy |
15,718
+1,730
| +12% | +$66.1K | 0.01% | 506 |
|
|
2025
Q1 | $542K | Sell |
13,988
-5
| -0% | -$183 | 0.01% | 513 |
|
|
2024
Q4 | $473K | Buy |
13,993
+40
| +0.3% | +$1.44K | ﹤0.01% | 546 |
|
|
2024
Q3 | $570K | Buy |
13,953
+2,614
| +23% | +$107K | 0.01% | 492 |
|
|
2024
Q2 | $437K | Sell |
11,339
-466
| -4% | -$19.6K | ﹤0.01% | 520 |
|
|
2024
Q1 | $506K | Buy |
11,805
+1,845
| +19% | +$76.1K | 0.01% | 504 |
|
|
2023
Q4 | $369K | Sell |
9,960
-639
| -6% | -$22.9K | ﹤0.01% | 547 |
|
|
2023
Q3 | $384K | Sell |
10,599
-1,193
| -10% | -$42.3K | ﹤0.01% | 510 |
|
|
2023
Q2 | $420K | Sell |
11,792
-515
| -4% | -$18.5K | 0.01% | 506 |
|
|
2023
Q1 | $438K | Sell |
12,307
-800
| -6% | -$28K | 0.01% | 485 |
|
|
2022
Q4 | $461K | Buy |
13,107
+680
| +5% | +$22.6K | 0.01% | 468 |
|
|
2022
Q3 | $366K | Sell |
12,427
-145
| -1% | -$5.5K | 0.01% | 497 |
|
|
2022
Q2 | $684K | Buy |
12,572
+183
| +1% | +$10.1K | 0.01% | 388 |
|
|
2022
Q1 | $684K | Sell |
12,389
-374
| -3% | -$20.3K | 0.01% | 410 |
|
|
2021
Q4 | $712K | Sell |
12,763
-797
| -6% | -$41.5K | 0.01% | 390 |
|
|
2021
Q3 | $656K | Buy |
13,560
+628
| +5% | +$31.5K | 0.01% | 397 |
|
|
2021
Q2 | $652K | Sell |
12,932
-974
| -7% | -$46.8K | 0.01% | 390 |
|
|
2021
Q1 | $630K | Sell |
13,906
-728
| -5% | -$33K | 0.01% | 383 |
|
|
2020
Q4 | $684K | Sell |
14,634
-1,835
| -11% | -$84.3K | 0.01% | 359 |
|
|
2020
Q3 | $785K | Sell |
16,469
-208
| -1% | -$10.4K | 0.01% | 322 |
|
|
2020
Q2 | $860K | Buy |
16,677
+367
| +2% | +$18.8K | 0.02% | 306 |
|
|
2020
Q1 | $783K | Buy |
16,310
+1,278
| +9% | +$68.2K | 0.02% | 291 |
|
|
2019
Q4 | $892K | Sell |
15,032
-90
| -0.6% | -$5.01K | 0.02% | 339 |
|
|
2019
Q3 | $815K | Buy |
15,122
+10
| +0.1% | +$514 | 0.02% | 342 |
|
|
2019
Q2 | $755K | Buy |
15,112
+1,184
| +9% | +$59.4K | 0.02% | 354 |
|
|
2019
Q1 | $727K | Buy |
13,928
+90
| +0.7% | +$4.5K | 0.02% | 356 |
|
|
2018
Q4 | $660K | Buy |
13,838
+320
| +2% | +$15.8K | 0.02% | 358 |
|
|
2018
Q3 | $678K | Buy |
13,518
+80
| +0.6% | +$4.07K | 0.02% | 385 |
|
|
2018
Q2 | $677K | Buy |
13,438
+170
| +1% | +$8.56K | 0.02% | 378 |
|
|
2018
Q1 | $647K | Buy |
13,268
+174
| +1% | +$8.1K | 0.02% | 371 |
|
|
2017
Q4 | $580K | Sell |
13,094
-514
| -4% | -$23.7K | 0.01% | 390 |
|
|
2017
Q3 | $690K | Buy |
13,608
+32
| +0.2% | +$1.62K | 0.02% | 337 |
|
|
2017
Q2 | $731K | Sell |
13,576
-269
| -2% | -$14.3K | 0.02% | 307 |
|
|
2017
Q1 | $729K | Buy |
13,845
+7,710
| +126% | +$391K | 0.02% | 295 |
|
|
2016
Q4 | $295K | Sell |
6,135
-983
| -14% | -$48.6K | 0.01% | 489 |
|
|
2016
Q3 | $383K | Sell |
7,118
-504
| -7% | -$27.6K | 0.01% | 409 |
|
|
2016
Q2 | $412K | Sell |
7,622
-556
| -7% | -$29.3K | 0.01% | 385 |
|
|
2016
Q1 | $414K | Sell |
8,178
-1,428
| -15% | -$71.1K | 0.01% | 374 |
|
|
2015
Q4 | $484K | Buy |
9,606
+135
| +1% | +$6.88K | 0.02% | 335 |
|
|
2015
Q3 | $455K | Buy |
9,471
+3,021
| +47% | +$157K | 0.02% | 336 |
|
|
2015
Q2 | $335K | Buy |
6,450
+1,705
| +36% | +$96K | 0.01% | 422 |
|
|
2015
Q1 | $273K | Buy |
4,745
+289
| +6% | +$16.6K | 0.01% | 463 |
|
|
2014
Q4 | $238K | Buy |
4,456
+569
| +15% | +$31.8K | 0.01% | 500 |
|
|
2014
Q3 | $223K | Sell |
3,887
-3,472
| -47% | -$213K | 0.01% | 509 |
|
|
2014
Q2 | $491K | Buy |
7,359
+582
| +9% | +$39.4K | 0.02% | 292 |
|
|
2014
Q1 | $452K | Buy |
6,777
+2,141
| +46% | +$145K | 0.02% | 299 |
|
|
2013
Q4 | $309K | Buy |
4,636
+75
| +2% | +$4.86K | 0.01% | 410 |
|
|
2013
Q3 | $286K | Buy |
4,561
+800
| +21% | +$51.5K | 0.01% | 408 |
|
|
2013
Q2 | $234K | Buy |
+3,761
| New | +$239K | 0.01% | 461 |
|
Other funds holding GSK
JEST
Johnson Investment Counsel's GSK Position: Q2 2026 in Review
Johnson Investment Counsel reduced its GSK (GSK) stake by 7.7% in Q2 2026, selling an estimated $51.9K and leaving 11,753 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #559.
Johnson Investment Counsel first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $892K in Q4 2019. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Johnson Investment Counsel held 11,753 shares of GSK worth $616K as of Q2 2026.
- Johnson Investment Counsel sold 982 GSK shares in Q2 2026, an estimated $51.9K.
- GSK made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #559 holding.
- Johnson Investment Counsel first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
- Johnson Investment Counsel's GSK position peaked at $892K in Q4 2019.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.